Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ChiCTR2600128745) titled 'Study on Precision Dosing Strategies of Anti-infective Agents in the Very Early Stage of Kidney Transplantation' on July 24.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Zhongnan Hospital of Wuhan University
Condition:
None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-08-01
Target Sample Size: Kidney transplant very early anti-infection treatment observation group:40;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=333334
Disclaimer: Curated by HT Syndication....